A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia
| ISRCTN | ISRCTN51232664 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN51232664 |
| Secondary identifying numbers | N0079096832 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 30/11/2015
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Charles Montgomery
Scientific
Scientific
Department of Mental Health
University of Exeter
Wonford House Hospital
Dryden Road
Exeter
EX2 5AF
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia |
| Study objectives | Is venlafaxine an effective antidepressant for depression amongst persons with lymphoma or leukaemia? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Depression amongst persons with lymphoma or leukaemia |
| Intervention | A randomized controlled trial of venlafaxine versus placebo |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Venlafaxine |
| Primary outcome measure | Hamilton Rating Scale for Depression |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 07/01/2001 |
| Completion date | 31/12/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Persons with lymphoma or leukaemia with depression as assessed using the Hamilton Rating Scale for Depression. |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 07/01/2001 |
| Date of final enrolment | 31/12/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
University of Exeter
Exeter
EX2 5AF
United Kingdom
EX2 5AF
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Hospital/treatment centre
Devon Partnership NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
30/11/2015: no publications found on PubMed.
